A big thank you to ARCS Australia or once again delivering a highly successful conference filled with insightful conversations, valuable connections, and thought-provoking discussions across the life sciences sector. This year’s theme, “Life Sciences Unlocked: Shaping the Next Era,” lived up to expectations.

We thoroughly enjoyed attending and contributing to the event. Here’s a quick recap of Lucid Health Consulting’s involvement:

🔹 CEO Breakfast

Our Principal Consultant, George Papadopoulos, attended the CEO Breakfast, which Lucid Health Consulting was proud to sponsor as the inaugural breakfast sponsor in 2024. It was a great opportunity to connect with leaders from across the sector and discuss the opportunities and challenges shaping the future of life sciences.

🔹 From Functional Depth to Strategic Fluency: A Workshop for Medical Affairs & Life Sciences Professionals (Day 1)

George joined an outstanding panel of speakers including  Faizz Fattah, Sharmia Bakar, Marina van der Merwe, Orin Chisholm, Joe Badolato, Bas Ebaid, and Nina Mapson Bone.

The workshop brought together professionals from Medical Affairs, Market Access, Regulatory Affairs, Clinical Development, and the broader life sciences ecosystem to explore a critical question:

How do we evolve from technical experts into strategic leaders who can influence, collaborate, and create meaningful impact across functions?

Through interactive discussions, live polling, and shared experiences, participants identified key capabilities they are looking to strengthen, including Strategic influence, Business acumen, AI fluency, public speaking and more.

One clear takeaway was that strategic capability development doesn’t develop by accident. It comes from actively seeking new perspectives, collaboration and continuously investing in personal and professional learning.

🔹 Chairing the “Navigating Pre-Registration Access: Ensuring Continuity of Supply Between Trial Completion and PBS Reimbursement” Workshop (Day 2)

George had the privilege of chairing this important discussion alongside panellists Matt Zeller, Con Konstantopoulos, and Krystal Barter, exploring the challenges and opportunities associated with ensuring patient access during the period between clinical trial completion and PBS reimbursement.

Proposed Solution Directions: What “Better” Could Look Like

• Platform-first approach (logistics and discoverability)
  Create a platform that receives enrolment/order requests and routes supply through the most appropriate channel. Focus on improving systems and processes rather than rebuilding infrastructure or adding manual steps.

• Patient-centred program design and communication
  Many patients are unaware that market access programs exist, with visibility and navigation often falling short. Over-reliance on clinicians as the primary access funnel creates a significant failure point given workload pressures and competing priorities. Patients and consumers should be involved earlier in designing practical access pathways (not just consultation).

• National alignment and cross-sector collaboration
  The access gap must be recognised as a shared national challenge. Moving beyond siloed conversations toward pragmatic, cross-ecosystem problem-solving will be critical. While government has an important role, it must balance competing priorities across hospitals, prevention, aged care, innovation, and R&D.

• A pivotal window for action
  There is a strong view that the next 12–24 months will be critical in shaping Australia’s access landscape and innovation competitiveness for the next 10–20 years.

🔹 Connecting at the Oncothera Booth

George also spent time with the team at Oncothera in the exhibition hall. As a member of the Oncothera Board of Directors, it was fantastic to see the level of engagement at the booth, with valuable discussions, new connections, and the exchange of ideas across industry, research, clinical practice, and patient advocacy.

Finally, congratulations to ARCS on its evolution to LifeSciences Australia. This exciting transition builds on decades of credibility and trust while better reflecting the organisation’s growing role across Australia’s life sciences sector.

We look forward to seeing how LifeSciences Australia continues to support and advance the industry in the years ahead. You can find out more here: LifeSciences Australia – About the Change

Thank you again to ARCS Australia for hosting such a valuable event. We are already looking forward to next year.

The post ARCS Australia 2026 Annual Conference appeared first on Lucid Health Consulting | Experience Matters.

➡️ Medicines Australia’s Horizon Scanning: Medicines of Tomorrow

A gathering of patients, policymakers, researchers, regulators, and industry leaders, all united by a vision for an agile, equitable system that keeps patients at the centre.

As proud members of Medicines Australia, Lucid Health Consulting shares their vision to make the PBS stronger and more responsive to the needs of patients.

➡️ Medicines Australia’s PharmAus 2025

From Minister Mark Butler’s commitment to advancing HTA reform, to interactive exhibits that brought patient experience to life (VR disease simulations, postpartum haemorrhage demos, vision impairment goggles, and more) this event reminded us that innovation only matters if it improves lives.

➡️ Neurological Alliance Australia’s National Action Plan Launch.

The Blueprint for a National Action Plan for Neurological Conditions at Parliament House in Canberra.

The plan outlines how Australia could save $7 billion annually by implementing a national strategy for neurological conditions. Commissioned by the Neurological Alliance Australia (NAA) and developed by our team at Lucid Health Consulting, new economic modelling identifies significant opportunities to improve productivity, reduce preventable hospitalisations, and deliver more coordinated care across the health, disability and aged care systems.

This launch was a vital step toward coordinated, inclusive care as well as person-centred, data-driven policy. We are so proud to be part of this important guide for long-term national reform.

👉 View the Blueprint here: https://lnkd.in/gFgt3cWD

➡️ Rare Cancers Australia’s CanForum 25

A decade strong, this forum put rare cancer patients and families at the heart of the conversation, weaving personal stories with policy, genomics, and supportive care. A powerful reminder that empathy must sit alongside evidence in cancer care.

At Lucid Health Consulting, we know that real change in healthcare happens when diverse voices come together. Patients, policymakers, researchers, and industry, to turn ideas into action. With over 75 years of combined experience, our leadership team is supported by specialists across health economics, regulatory affairs, reimbursement, HTA, market and patient access, and statistics.

EMAIL: info@lucidhealthcon.com

PHONE: + 61 2 8964 9600

Follow us on LinkedIn HERE

The post Australian healthcare events in Canberra – September 2025 appeared first on Lucid Health Consulting | Experience Matters.

Our research spans a diverse range of timely topics, and we look forward to contributing fresh insights to this year’s discussions.

📍 Glasgow, UK | 9–12 November 2025
ISPOR Europe is a must-attend event for healthcare stakeholders, bringing together researchers, academicians, regulators, payers, policy makers, industry leaders, providers, and patient organisations.

This year’s conference theme, “Powering Value and Access Through Patient-Centered Collaboration,” highlights the importance of building strong partnerships across the healthcare ecosystem to accelerate patient-focused decision-making on value and access.

Over the coming weeks, we’ll be sharing more details about our abstracts, presenters, and attendees. If you’re heading to ISPOR Europe, please reach out via our email info@lucidhealthcon.com

👉 Learn more about ISPOR Europe 2025 and explore the full program here: ISPOR Europe 2025

EMAIL: info@lucidhealthcon.com

PHONE: + 61 2 8964 9600

Follow us on LinkedIn HERE

The post ISPOR Europe 2025 – 14 Abstracts accepted! appeared first on Lucid Health Consulting | Experience Matters.

The AusMedtech Annual Conference is Australia’s premier event for the medical technology industry, bringing together visionary leaders, innovators, and changemakers to shape the future of healthcare. This year’s theme, “Innovation to Impact,” highlights how medtech innovation translates into real-world, life-changing outcomes.

In today’s rapidly evolving health landscape, medtech stands at the forefront of breakthroughs that save lives, enhance quality of care, and drive economic growth. The medtech conference invites stakeholders to reflect on how we can collectively address unmet medical needs, reduce healthcare disparities, and ensure equitable access to the benefits of innovation.

AusMedtech 2025 is more than a celebration of progress, it’s a platform for action, connection, and collaboration.

👥 Join us for our “Reimbursed & Ready – Winning in the Australian Market” workshop, part of the pre-conference activities at AusMedtech 25. Led by our Director, George Papadopoulos, and Reimbursement & HTA Lead, Blaise Agresta, this session will provide attendees with a practical understanding of Australia’s healthcare system, including key pathways, influential decision-making and effective strategies for reimbursement success.

George and Blaise will be at the conference too and are looking forward to catching up with delegates and sharing how Lucid Health Consulting helps clients navigate reimbursement pathways and unlock market access across Australia, New Zealand, and the Asia-Pacific.

🔗 Find out more and register here: AusMedtech 2025

We look forward to seeing you there!

The post Lucid Health Consulting Medtech Reimbursement workshop at AusMedtech 2025! appeared first on Lucid Health Consulting | Experience Matters.

At Lucid Health Consulting, our team is excited to attend this year’s conference and we are pleased to announce that we will have a booth in the Exhibition Hall once again. Visit us at Booth M16 to meet our team, learn more about how we assist our clients in achieving market access for their pharmaceutical, medical devices, biotech products and medical technologies in Australia and the Asia-Pacific region; and explore our online resources. We’d love to connect and answer any questions you may have!

Find out more about the 2024 ARCS Annual Conference, view the comprehensive programme and register by visiting ➡ 2024 ARCS Annual Conference (eventsair.com)

The post The 2024 ARCS Australia Annual Conference – ICC, Sydney. 12-14 June. appeared first on Lucid Health Consulting | Experience Matters.

Just over two weeks to go until AusMedtech 2024, hosted by AusBiotech, in Adelaide, on 22-23 May. It’s not too late to register for AusMedtech 2024 where industry leaders, healthcare professionals, and tech enthusiasts converge to explore the latest advancements. Dive into cutting-edge discussions, hands-on demonstrations, and networking opportunities that shape the future of healthcare technology.

Our Director George Papadopoulos,Sarah Griffin is excited to attending the conference as well as participating as a panellist on the Reimbursement Session on Wednesday 22 May, 4.15pm – 5.10pm with session chair Dell Kingsford Smith and fellow panellists:

Sarah Griffin, Director, MedTechnique Consulting
Penny Shakespeare, Deputy Secretary, Department of Health and Aged Care
Polo Guilbert-Wright – Wright, Senior Director Government Affairs ANZ, Edwards Lifesciences
Nicola Leavold, Commercial Director Australasia, BXTA

To register and view the comprehensive conference programme for AusMedtech 2024, use the link: AusMedtech 2024

The post AusMedtech 2024 appeared first on Lucid Health Consulting | Experience Matters.

The post ISPOR Europe 2023, 12-15 November, with our Poster. appeared first on Lucid Health Consulting | Experience Matters.

The post HTAi 2023 Annual Meeting | LHC Poster and Presentation. appeared first on Lucid Health Consulting | Experience Matters.

Covering key HEOR topics, including:

• Clinical Outcomes
• Economic Evaluation
• Epidemiology and Public Health
• Health Policy and Regulatory
• Health Service Delivery and Process of Care
• Health Technology Assessment

And much more!

Our Director’s George Papadopoulos and Michael Aristides are looking forward to attending and will be available to meet in-person throughout the conference.

In addition, George is excited to participate as a Moderator for the Regional Case Studies Session, on Tuesday, May 9, 2023| 4:45PM – 5:45PM.  Session Link: https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-2023/program/program/?sessionTypes=case-studies

Find out more about #ISPOR2023, via the ISPOR Conference link: ISPOR – Registration Information

The post ISPOR 2023 Boston, MA, USA, 7-10 May appeared first on Lucid Health Consulting | Experience Matters.

This year’s conference theme was: Collaborating Across Borders: Building & Using Evidence to Enable Access.

The conference provided attendees with opportunities to network in-person and virtually with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.

We were thrilled that our co-authored Abstract Poster, titled: “Cost Utility and Budget Impact of Closed Loop Upper Airway Stimulation (UAS) for the Treatment of Moderate to Severe Obstructive Sleep Apnea from an Australian Health Care System Perspective”, was selected and presented as Poster EE69 at The ISPOR Europe 2022 Global Conference, in Vienna on Monday, 07 November by our partners Hemant Rathi and Amit Gupta. from Skyward Analytics.

Poster title: “Cost Utility and Budget Impact of Closed Loop Upper Airway Stimulation (UAS) for the Treatment of Moderate to Severe Obstructive Sleep Apnea from an Australian Health Care System Perspective”, co-authored by our Partner and Director, George Papadopoulos, Sarah Griffin, Hemant Rathi and Amit Gupta.

VIEW AND DOWNLOAD THE FULL POSTER HERE

About the Author

George Papadopoulos, BSc(Hons), GDipEpi, MAICD

George is a healthcare pricing and reimbursement professional with over 25 years’ experience across in local and international healthcare companies.  George worked in both local operating company and global levels in increasing levels of responsibility for leading pharmaceutical companies in Australia, Belgium and the United States.  He has previously worked for Pharmacia, Johnson and Johnson, Schering-Plough and Merck. George has experience in the pharmaceutical, biotech and medical device industry, including clinical research, health economics, reimbursement and pricing.

George is currently Partner and Director of Lucid Health Consulting, a strategic healthcare consultancy providing services to assist healthcare companies with the market access for their pharmaceutical, biotech, medical device or diagnostic technologies. These services include health economics strategy, health technology assessment, pricing and reimbursement strategy development and advisory board participation.

George received his BSc(Hons) from the University of Sydney and Grad Dip Epi(Pharmacoepi) from University of Newcastle. He is Past-President of the Board of ARCS; Member of Heath Economics Expert Panel of Ausbiotech and a member of HTAi (Health Technology Association International), iHEA (International Health Economics Association), ISPOR and ISPOR Australian Chapter and of the AICD (Australian Institute of Company Directors).

Connect with George on LinkedIn

The post ISPOR Europe 2022, 6 – 9 November with Poster appeared first on Lucid Health Consulting | Experience Matters.